#zuranolone

[ follow ]
#postpartum-depression

A new $16,000 postpartum depression drug is here. How will insurers handle it?

Zuranolone, a treatment for postpartum depression, is both novel and expensive, with insurers yet to publish coverage criteria.
Insurers handling of zuranolone similar to predecessor brexanolone, with concerns about restrictive coverage guidance and fail-first requirements.

There's a new prescription pill for postpartum depression. How will coverage work?

Struggle for postpartum depression care led to policy changes at Kaiser Permanente
Uncertainty in insurance coverage for new postpartum depression treatment zuranolone

A new $16,000 postpartum depression drug is here. How will insurers handle it?

Zuranolone, a treatment for postpartum depression, is both novel and expensive, with insurers yet to publish coverage criteria.
Insurers handling of zuranolone similar to predecessor brexanolone, with concerns about restrictive coverage guidance and fail-first requirements.

There's a new prescription pill for postpartum depression. How will coverage work?

Struggle for postpartum depression care led to policy changes at Kaiser Permanente
Uncertainty in insurance coverage for new postpartum depression treatment zuranolone
morepostpartum-depression

Clinicians May Not Prescribe New Postpartum Depression Drug

The availability and prescription of a new drug for postpartum depression (PPD) will depend on how insurers cover the medication.
The expected high cost of the drug could make it inaccessible to many patients.
Providers are optimistic about the potential benefits of the drug, but still need more information regarding safety for infants and the duration of treatment effects.
[ Load more ]